Does mechanism matter? Unrelated neurotoxicants converge on cell cycle and apoptosis during neurodifferentiation

Theodore A Slotkin1, Frederic J Seidler

  • 1Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC, USA. t.slotkin@duke.edu

Insights

Diverse developmental neurotoxicants, including pesticides and metals, converge on common cellular pathways. These pathways regulate cell cycle and apoptosis, leading to neural cell loss and similar outcomes.

Area of Science:

  • Neuroscience
  • Toxicology
  • Molecular Biology

Background:

  • Developmental neurotoxicants can cause neural cell loss with similar functional outcomes despite different mechanisms.
  • Understanding the common pathways targeted by these toxicants is crucial for predicting and mitigating neurodevelopmental deficits.

Purpose of the Study:

  • To investigate whether mechanistically distinct developmental neurotoxicants converge on common cellular pathways.
  • To compare the effects of an organophosphate pesticide (diazinon), an organochlorine pesticide (dieldrin), and a metal (Ni2+) on cell cycle and apoptosis genes in differentiating PC12 cells.

Main Methods:

  • Utilized PC12 cells as an in vitro model of neuronal development.
  • Applied diazinon, dieldrin, and Ni2+ at 30μM for 24 or 72 hours.
  • Employed microarrays to analyze mRNA expression of nearly 400 genes involved in cell cycle and apoptosis pathways.

Main Results:

  • All three agents significantly altered gene expression in both cell cycle (40-45%) and apoptosis (30-40%) pathways.
  • A substantial overlap was observed, with 80 cell cycle and 56 apoptosis genes commonly affected by all agents.
  • Concordance analysis revealed highly significant correlations in the transcriptional changes across all pairwise agent comparisons.

Conclusions:

  • Disparate developmental neurotoxicants converge on common cellular pathways regulating neural cell proliferation and programmed death.
  • This convergence provides a mechanistic link between diverse toxicants and observed neural cell deficits.
  • Focusing on common downstream pathways may be more critical than identifying the initial mechanism of action for developmental neurotoxicants.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...